A Technical Comparison of Human Papillomavirus Genotyping Assays from a Population-Based Cervical Cancer Screening in South Central Ethiopia.

HPV PCR test accuracy HPV test complexity HPV testing LMIC analytical performance

Journal

Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700

Informations de publication

Date de publication:
2022
Historique:
received: 01 02 2022
accepted: 27 05 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

High-risk Human Papillomavirus (HPV) is the most important cause of cervical cancer. The highest burden of disease is seen in Low- and Low-Middle-Income Countries (LMIC). Several new HPV screening assays have been developed for high-risk HPV (hr-HPV) testing. We compared the performance and adequacy of three HPV genotyping assays on samples from a population of rural women in south-central Ethiopia. One hundred and ten cervical swabs from rural women screened for HPV were assayed. HPV DNA was tested using MPG-Luminex Assay, Anyplex II HPV HR Detection, and EUROArray HPV. MPG-Luminex Assay was used as a reference method to compute the sensitivity and specificity of the two commercial assays in detecting hr-HPV infections. Of the 110 samples, MPG-Luminex Assay found 18.2% positive for the 14 hr-HPV and 7.3% for the probable hr-HPV genotypes. Anyplex™ II HPV HR Detection assay and EUROArray HPV Assay identified 21.82% and 12.7% samples, respectively, for the 14 hr-HPVs and both 7.3% for the probable hr-HPV genotypes (κ=0.734). Among the 14 hr-HPV genotypes, the genotype-specific agreement of the three HPV genotyping assays was moderate or better for HPV16, 31, 35, 39, 52, 56, 66 and 68. The aggregated sensitivity in detecting the 14 hr-HPV infections of Anyplex™ II HPV HR Detection and EUROArray HPV assays was high, 100% and 70%, respectively. The specificities of Anyplex™ II HPV HR Detection and EUROArray HPV were 95.6% and 100%, respectively. The three evaluated assays showed similar analytical performance in the detection of hr-HPV infections and moderate or better concordance in HPV genotyping. This study is part of the ongoing cluster-randomized trial that has been registered in clinicaltrials.gov (NCT03281135) on September 13, 2017.

Identifiants

pubmed: 35937937
doi: 10.2147/CMAR.S360712
pii: 360712
pmc: PMC9346300
doi:

Banques de données

ClinicalTrials.gov
['NCT03281135']

Types de publication

Journal Article

Langues

eng

Pagination

2253-2263

Informations de copyright

© 2022 Teka et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest in relation to this work.

Références

J Clin Microbiol. 2008 Mar;46(3):1050-9
pubmed: 18199790
Int J Cancer. 2017 May 15;140(10):2192-2200
pubmed: 28006858
Cancer Prev Res (Phila). 2019 Sep;12(9):609-616
pubmed: 31337647
J Clin Virol. 2016 Mar;76 Suppl 1:S3-S13
pubmed: 26601820
Front Public Health. 2017 Nov 20;5:307
pubmed: 29209603
Clin Microbiol Infect. 2015 Sep;21(9):817-26
pubmed: 25936581
Clin Microbiol Infect. 2020 Sep;26(9):1144-1150
pubmed: 32247892
Ann Intern Med. 1997 Jan 1;126(1):91-4
pubmed: 8992938
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Int J Cancer. 2012 Nov 1;131(9):1969-82
pubmed: 22623137
IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636
pubmed: 18354839
J Clin Virol. 2016 Mar;76:36-9
pubmed: 26809131
J Clin Microbiol. 2014 Nov;52(11):3996-4002
pubmed: 25210073
Virol J. 2012 Nov 06;9:262
pubmed: 23131123
J Clin Virol. 2009 Jun;45(2):100-4
pubmed: 19394266
Papillomavirus Res. 2019 Jun;7:173-175
pubmed: 31002883
PLoS One. 2020 Sep 1;15(9):e0238291
pubmed: 32870941
Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):1033-6
pubmed: 27048314
Cancer Prev Res (Phila). 2020 Jul;13(7):593-600
pubmed: 32371553
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
J Clin Virol. 2016 Mar;76 Suppl 1:S14-S21
pubmed: 26522865
Clin Microbiol Infect. 2020 May;26(5):579-583
pubmed: 31539637
BMJ. 2016 Oct 4;355:i4924
pubmed: 27702796
J Med Virol. 2011 Jun;83(6):1042-7
pubmed: 21503918
Int J Cancer. 2021 Feb 1;148(3):723-730
pubmed: 32875552
Clin Microbiol Infect. 2021 Aug;27(8):1083-1095
pubmed: 33975008
Nat Rev Cancer. 2018 Apr;18(4):240-254
pubmed: 29497146
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482
Am J Clin Pathol. 2010 Aug;134(2):193-9
pubmed: 20660320
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Papillomavirus Res. 2017 Dec;4:79-84
pubmed: 29179874
Am J Obstet Gynecol. 2017 Mar;216(3):264.e1-264.e7
pubmed: 27825977

Auteurs

Brhanu Teka (B)

Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Gynaecology Martin-Luther-University, Halle-Wittenberg, Germany.

Muluken Gizaw (M)

Department of Gynaecology Martin-Luther-University, Halle-Wittenberg, Germany.
School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University, Halle-Wittenberg, Germany.

Ededia Firdawoke (E)

Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Adamu Addissie (A)

School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Tesfamichael Awoke Sisay (TA)

School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Carola Schreckenberger (C)

Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, 13353, Germany.

Anna Sophie Skof (AS)

Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, 13353, Germany.

Sarah Thies (S)

Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, 13353, Germany.

Adane Mihret (A)

Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia.

Eva Johanna Kantelhardt (EJ)

Department of Gynaecology Martin-Luther-University, Halle-Wittenberg, Germany.
Institute for Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University, Halle-Wittenberg, Germany.

Tamrat Abebe (T)

Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Andreas M Kaufmann (AM)

Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, 13353, Germany.

Classifications MeSH